文献速递神经外周血管MRDSA

对比增强MR血管成像评估治疗后脑动静脉畸形残留的诊断价值:系统评价与meta分析

Value of contrast-enhanced MR angiography for the follow-up of treated brain arteriovenous malformations: systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2023-05-06

该系统评价与meta分析纳入7项研究共223例患者,评估对比增强MR血管成像(CE-MRA)识别治疗后脑动静脉畸形(AVM)残留的诊断价值。汇总敏感度为0.77(95%CI 0.65-0.86),特异度为0.97(95%CI 0.82-1.00),AUC为0.89(95%CI 0.86-0.92)。CE-MRA对治疗后AVM随访有良好诊断价值和高特异度,但敏感度中等,4D CE-MRA敏感度低于3D CE-MRA。

要点

  • CE-MRA识别治疗后AVM残留的汇总敏感度0.77、特异度0.97,高特异度有助于确认无残留。
  • 4D CE-MRA检测治疗后AVM的敏感度低于3D CE-MRA,阅片时需注意序列选择的影响。
  • CE-MRA可作为随访中识别残留AVM、减少过度DSA检查的辅助手段。

核心结论

  • CE-MRA对治疗后脑AVM随访具有良好诊断价值和高特异度,汇总敏感度0.77、特异度0.97、AUC 0.89。

研究设计与样本

  • 系统评价与meta分析,检索PubMed、Web of Science、Embase和Cochrane Library数据库。
  • 纳入7项合格研究,共223例参与者,采用QUADAS-2工具评价方法学质量。
  • 采用双变量混合效应模型计算汇总敏感度和特异度,Deeks漏斗图检测发表偏倚,I2检验异质性。

诊断标准与关键数值

  • 以金标准为参照,CE-MRA检测治疗后脑AVM残留的汇总敏感度为0.77(95%CI 0.65-0.86)。
  • 汇总特异度为0.97(95%CI 0.82-1.00),基于SROC曲线的AUC为0.89(95%CI 0.86-0.92)。
  • 特异度存在异质性(I2=74.23%),4D CE-MRA检测治疗后AVM的敏感度低于3D CE-MRA。

临床应用与阅片要点

  • CE-MRA高特异度有助于在随访中识别无残留AVM,可能减少不必要的DSA复查。
  • 阅片时需注意4D CE-MRA敏感度低于3D CE-MRA,阴性结果应结合临床和其他序列综合判断。

局限性

  • 纳入样本量小(7项研究、223例),存在异质性(尤其特异度I2=74.23%),且受多种因素影响诊断准确性,需大样本前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To estimate the diagnostic value of contrast-enhanced MR angiography (CE-MRA) in identifying residual brain arteriovenous malformations (AVMs) after treatment.

METHODS: We retrieved appropriate references from the electronic databases of PubMed, Web of Science, Embase, and Cochrane Library, and then evaluated the methodology quality of included references using the QUADAS-2 tool. We calculated the pooled sensitivity and specificity by applying a bivariate mixed-effects model and detected the publication bias using Deeks' funnel plot. The values of I2 were used to test heterogeneity and meta-regression analyses were performed to search for the causes of heterogeneity.

RESULTS: We included 7 eligible studies containing 223 participants. Compared with a gold standard, the overall sensitivity and specificity of CE-MRA in detecting residual brain AVMs were 0.77 (95% CI 0.65-0.86) and 0.97 (95% CI 0.82-1.00), respectively. Based on the summary ROC curve, the AUC was 0.89 (95% CI 0.86-0.92). Heterogeneity could be observed in our study, especially for the specificity (I2 = 74.23%). Furthermore, there was no evidence of publication bias.

CONCLUSIONS: Our study provides evidence that CE-MRA has good diagnostic value and specificity for the follow-up of treated brain AVMs. Nevertheless, considering the small sample size, heterogeneity, and many factors that may affect the diagnostic accuracy, future large-sample, prospective studies are necessary to validate the results.

KEY POINTS: • The pooled sensitivity and specificity of contrast-enhanced MR angiography (CE-MRA) in detecting residual arteriovenous malformations (AVMs) were 0.77 (95% CI 0.65-0.86) and 0.97 (95% CI 0.82-1.00). • The four-dimensional CE-MRA showed less sensitivity than the three-dimensional CE-MRA for treated AVMs. • CE-MRA is helpful to identify residual AVMs and reduce excessive DSA during follow-up.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhuo, Chang, Chen, et al. Value of contrast-enhanced MR angiography for the follow-up of treated brain arteriovenous malformations: systematic review and meta-analysis. Eur Radiol. 2023. PMID: 37148354. doi:10.1007/s00330-023-09714-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。